NSI Equity Snapshot
CONCORDBIO Weekly Equity Report
Concord Biotech Limited
What the company does
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, and nystatin …
What the weekly tape is saying
CONCORDBIO closed the latest completed week at 1,354 INR. The 4-week return is 19.2% and the 12-week return is 23.9%. Trend Signal is inactive, Market Dynamics is 0.83. Setup signature: Deep recovery attempt with a 54/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,214 INR
- Vs Trend Line
- 11.5%
- Fair Value
- 1,531 INR
- Vs Fair Value
- -11.5%
- 52W High
- 2,132 INR
- 52W Low
- 987.0 INR
- Drawdown
- -36.5%
- Range Position
- 32.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- IN Healthcare
- Sector Rank
- 11 of 161
- Sector Percentile
- 93.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 18 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 3 of 12
- Avg 1W
- 2.1%
- Avg 4W
- 10.0%
- Trend Breadth
- 50.0%
- Positive RS
- 50.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.83
- 4W MD Change
- 423.6%
- Relative Strength
- 1.98
- 4W RS Change
- 111.6%
- Expectation
- Undecided
- Probability
- 47.03%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.5M
- 13W Average
- 1.8M
- 52W Average
- 1.3M
- Vs 13W
- 1.4x
- Vs 52W
- 2.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.7%
- 52W Volatility
- 6.2%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 5.2% / -4.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- INR
- Market Cap
- 110.0B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,354 INR | 11.9% | 1,214 INR | 1,531 INR | 0.83 | 1.98 | 2.5M | Off |
| 5 Jun 2026 | 1,210 INR | 15.1% | 1,219 INR | 1,532 INR | 0.65 | -8.72 | 8.8M | Off |
| 29 May 2026 | 1,051 INR | -8.9% | 1,226 INR | 1,534 INR | 0.56 | -21.96 | 636.7K | Off |
| 22 May 2026 | 1,153 INR | 1.6% | 1,239 INR | 1,537 INR | 0.61 | -15.72 | 554.4K | Off |
| 15 May 2026 | 1,135 INR | -3.3% | 1,249 INR | 1,540 INR | 0.16 | -17.12 | 684.9K | Off |
| 8 May 2026 | 1,174 INR | 2.8% | 1,262 INR | 1,543 INR | -0.10 | -16.51 | 1.2M | Off |
| 1 May 2026 | 1,142 INR | 12.4% | 1,277 INR | 1,545 INR | -0.56 | -18.59 | 2.1M | Off |
| 24 Apr 2026 | 1,016 INR | -6.1% | 1,292 INR | 1,548 INR | -1.07 | -27.57 | 1.0M | Off |
| 17 Apr 2026 | 1,082 INR | 2.0% | 1,310 INR | 1,552 INR | -1.13 | -24.91 | 1.8M | Off |
| 10 Apr 2026 | 1,060 INR | 3.4% | 1,331 INR | 1,555 INR | -1.18 | -26.12 | 1.7M | Off |
| 3 Apr 2026 | 1,025 INR | 1.0% | 1,350 INR | 1,559 INR | -1.01 | -25.05 | 731.4K | Off |
| 27 Mar 2026 | 1,015 INR | -7.1% | 1,371 INR | 1,563 INR | -0.75 | -26.77 | 724.5K | Off |
| 20 Mar 2026 | 1,092 INR | -7.6% | 1,393 INR | 1,567 INR | -0.45 | -22.83 | 1.2M | Off |
| 13 Mar 2026 | 1,182 INR | -2.1% | 1,415 INR | 1,570 INR | -0.62 | -17.24 | 626.5K | Off |